Trending NewsTrending NewsNASDAQ:TNDM Tandem Diabetes Care (TNDM) Stock Price, News & Analysis $11.52 -2.87 (-19.94%) Closing price 08/7/2025 04:00 PM EasternExtended Trading$11.61 +0.09 (+0.78%) As of 08/7/2025 07:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock About Tandem Diabetes Care Stock (NASDAQ:TNDM) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Tandem Diabetes Care alerts:Sign Up Key Stats Today's Range$9.98▼$11.5650-Day Range$11.52▼$22.4452-Week Range$9.98▼$47.60Volume11.84 million shsAverage Volume1.76 million shsMarket Capitalization$767.35 millionP/E RatioN/ADividend YieldN/APrice Target$23.57Consensus RatingHold Company Overview Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California. Read More Tandem Diabetes Care Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks82nd Percentile Overall ScoreTNDM MarketRank™: Tandem Diabetes Care scored higher than 82% of companies evaluated by MarketBeat, and ranked 263rd out of 921 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.1 / 5Analyst RatingHold Consensus RatingTandem Diabetes Care has received a consensus rating of Hold. The company's average rating score is 2.27, and is based on 5 buy ratings, 9 hold ratings, and 1 sell rating.Amount of Analyst CoverageTandem Diabetes Care has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Tandem Diabetes Care's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Tandem Diabetes Care are expected to grow in the coming year, from ($1.68) to ($1.20) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Tandem Diabetes Care is -3.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Tandem Diabetes Care is -3.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioTandem Diabetes Care has a P/B Ratio of 2.87. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted15.16% of the outstanding shares of Tandem Diabetes Care have been sold short.Short Interest Ratio / Days to CoverTandem Diabetes Care has a short interest ratio ("days to cover") of 6.2.Change versus previous monthShort interest in Tandem Diabetes Care has recently increased by 3.59%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldTandem Diabetes Care does not currently pay a dividend.Dividend GrowthTandem Diabetes Care does not have a long track record of dividend growth. Sustainability and ESG4.9 / 5Environmental Score-0.64 Percentage of Shares Shorted15.16% of the outstanding shares of Tandem Diabetes Care have been sold short.Short Interest Ratio / Days to CoverTandem Diabetes Care has a short interest ratio ("days to cover") of 6.2.Change versus previous monthShort interest in Tandem Diabetes Care has recently increased by 3.59%, indicating that investor sentiment is decreasing. News and Social Media3.2 / 5News Sentiment0.77 News SentimentTandem Diabetes Care has a news sentiment score of 0.77. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.39 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 28 news articles for Tandem Diabetes Care this week, compared to 8 articles on an average week.Search InterestOnly 2 people have searched for TNDM on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days.MarketBeat Follows2 people have added Tandem Diabetes Care to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Tandem Diabetes Care insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 1.90% of the stock of Tandem Diabetes Care is held by insiders.Read more about Tandem Diabetes Care's insider trading history. Receive TNDM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Tandem Diabetes Care and its competitors with MarketBeat's FREE daily newsletter. Email Address TNDM Stock News HeadlinesToday's Analyst Rating Update for Tandem Diabetes Care (TNDM) | TNDM Stock NewsAugust 7 at 7:49 PM | gurufocus.comInsulet Peer Tandem Diabetes Underwhelming Earnings, Dull Outlook Drags StockAugust 7 at 2:12 PM | benzinga.comCrypto bros: Meet your replacementLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% worldwide. Now he’s applying the same expertise to the Bitcoin market. His system tracks 19 indicators to find quick Bitcoin profit opportunities. | Brownstone Research (Ad)Tandem Diabetes Care, Inc. (TNDM) Stock forecastsAugust 7 at 1:36 PM | uk.finance.yahoo.comForecasting The Future: 4 Analyst Projections For Tandem Diabetes CareAugust 7 at 1:36 PM | benzinga.comTandem Diabetes Care issues voluntary device correction for certain insulin pumpsAugust 7 at 9:32 AM | reuters.comTandem Diabetes Care Issues Voluntary Medical Device Correction for Select t:slim X2 Insulin ...August 7 at 9:23 AM | gurufocus.comTandem Diabetes Care Issues Voluntary Medical Device Correction for Select t:slim X2 Insulin PumpsAugust 7 at 9:22 AM | gurufocus.comSee More Headlines TNDM Stock Analysis - Frequently Asked Questions How have TNDM shares performed this year? Tandem Diabetes Care's stock was trading at $36.02 at the start of the year. Since then, TNDM stock has decreased by 68.0% and is now trading at $11.52. How were Tandem Diabetes Care's earnings last quarter? Tandem Diabetes Care, Inc. (NASDAQ:TNDM) posted its quarterly earnings data on Wednesday, August, 6th. The medical device company reported ($0.48) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.40) by $0.08. The firm's revenue for the quarter was up 8.5% compared to the same quarter last year. Read the conference call transcript. When did Tandem Diabetes Care's stock split? Shares of Tandem Diabetes Care reverse split on the morning of Tuesday, October 10th 2017.The 1-10 reverse split was announced on Monday, October 9th 2017. The number of shares owned by shareholders was adjusted after the market closes on Monday, October 9th 2017. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. Who are Tandem Diabetes Care's major shareholders? Tandem Diabetes Care's top institutional shareholders include Stephens Investment Management Group LLC (2.61%), Jennison Associates LLC (2.49%), Connor Clark & Lunn Investment Management Ltd. (1.18%) and Acadian Asset Management LLC (0.54%). Insiders that own company stock include Kim D Blickenstaff, Dick Allen, Leigh Vosseller, Jean-Claude Kyrillos, Kathleen Mcgroddy-Goetz, David B Berger, Shannon Marie Hansen and Mark David Novara. View institutional ownership trends. How do I buy shares of Tandem Diabetes Care? Shares of TNDM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Tandem Diabetes Care own? Based on aggregate information from My MarketBeat watchlists, some other companies that Tandem Diabetes Care investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), PayPal (PYPL), Alibaba Group (BABA) and Netflix (NFLX). Company Calendar Last Earnings8/06/2025Today8/08/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED INSTRUMENTS Sub-IndustryMedical Equipment Current SymbolNASDAQ:TNDM CIK1438133 Webwww.tandemdiabetes.com Phone(858) 366-6900FaxN/AEmployees2,650Year Founded2006Price Target and Rating Average Price Target for Tandem Diabetes Care$23.57 High Price Target$53.00 Low Price Target$13.00 Potential Upside/Downside+104.6%Consensus RatingHold Rating Score (0-4)2.21 Research Coverage14 Analysts Profitability EPS (Trailing Twelve Months)($2.78) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$96.03 million Net Margins-20.51% Pretax Margin-17.75% Return on Equity-59.02% Return on Assets-13.60% Debt Debt-to-Equity Ratio1.99 Current Ratio2.30 Quick Ratio1.81 Sales & Book Value Annual Sales$940.20 million Price / Sales0.82 Cash FlowN/A Price / Cash FlowN/A Book Value$4.01 per share Price / Book2.87Miscellaneous Outstanding Shares66,610,000Free Float65,341,000Market Cap$767.35 million OptionableOptionable Beta1.46 Social Links Beginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report This page (NASDAQ:TNDM) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredSell this, buy thatWhat you don’t own matters just as much as what you do. That’s the thinking behind Eric Fry’s long-time strate...InvestorPlace | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tandem Diabetes Care, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tandem Diabetes Care With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.